The University of North Carolina at Chapel Hill

Skip to main content

Eshelman School of Pharmacy

Go to Search Page

Back to Homeback to home » Accolades

Accolades

  • Christy Sherrill

    Christina Sherrill Receives $1,000 for Innovating Pharmacy Education Through Interactive Learning

    See More

    Sherrill received support from the American College of Clinical Pharmacy (ACCP) for International Implementation of a Web‑Based Escape Room with Embedded Principles of Pharmacist Independent Prescribing. The project promotes engaging, skills‑based learning in global pharmacy education.

  • Zhenwei Song

    Identifying Inflammatory Risks in AAV Gene Therapy: Zhenwei Song Awarded $100,000

    Song was awarded funding for Inflammatory Risk Factors in AAV Gene Therapy Efficacy and Safety from the American Society of Gene and Cell Therapy (ASGCT). The study investigates how inflammation affects gene therapy outcomes and patient safety.

  • Juliane Nguyen

    Juliane Nguyen Awarded $156,172 to Combine Nanotechnology and Anti‑inflammatory Therapy for Heart Attack Care

    Nguyen received support from the American Heart Association (AHA) for Anti‑inflammatory Peptidomimetic‑Loaded Zippersomes: A Combinatorial Heart Attack Treatment. This project explores a novel therapeutic approach to reduce cardiac injury following myocardial infarction.

  • Eileen Kennedy

    Targeting Parkinson’s Disease Signaling Pathways with Novel Peptides: Eileen Kennedy Awarded $35,515.35

    Kennedy received an award for Characterization of Constrained Peptides Targeting LRRK2 and Downstream Signaling, from Michael J Fox Foundation for Parkinson’s Research. The project supports Parkinson’s disease research through targeted therapeutic design.

  • Paul Watkins

    Paul Watkins Receives $763,647 Grant to Improve Safety and Effectiveness of Gene Therapy

    Watkins was funded by the NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) for Genetic Determinants of AAV Liver Transduction and Toxicity. This research examines how genetic variation influences AAV gene therapy performance and safety.

  • Liu Rihe

    Advancing Immune‑Based Treatments for Breast Cancer: Rihe Liu Secures $694,987

    Liu received support from the Department of Defense (DOD) for Innovative Immunotherapeutics for Breast Cancer Treatment. The project develops next‑generation immunotherapies aimed at improving efficacy and patient outcomes.

  • Will Zamboni

    William Zamboni Awarded $40,037 to Help Target Metastatic Colorectal Cancer with Novel Aptamers

    Deep Creek Pharma, LLC provided the award to Zamboni for STTR Phase I: Modified Thrombin Binding Aptamer Treatment of CRC Metastasis. This translational project evaluates a new targeted strategy for treating metastatic disease.

  • Ryan Gumpper

    Ryan Gumpper Awarded $70,000 for Designing Safer Psychedelic‑Inspired Therapies

    Gumpper received an award from The Brain and Behavior Research Foundation (National Alliance for Research on Schizophrenia and Depression (NARSAD)) for Characterization of Non‑hallucinogenic Psychedelic Analogs for Neuropsychiatric Disorders. The study explores therapeutic compounds that retain benefit while minimizing adverse effects.

  • Alison Axtman

    Discovering New Molecular Tools for Neurologic Disease: Alison Axtman Receives $57,500

    Axtman was funded for Identification of First‑in‑Class Ligands that Bind Glial Fibrillary Acidic Protein (GFAP). This research supports early‑stage discovery relevant to Alexander disease biology and treatment. The grant is sponsored by the End Alexander Disease Foundation

  • Sam Lai

    Sam Lai Awarded $107,710 grant to Advance Biologic Therapies for Metabolic Disease

    Lai received support for SBIR: Development and Evaluation of a Pegloticase Bio‑Better for Sustained Suppression of Fructose‑Induced Obesity from Mucommune, LLC. The project focuses on a next‑generation biologic to improve long‑term metabolic control.